dxlabs OÜ
Active Registry code 11503052
OÜ Tallinn Registered 5 May 2008
dxlabs OÜ is a OÜ based in Tallinn, registry code 11503052, status: active. Main activity: Research and experimental development on natural sciences and engineering. According to EMTA, turnover for Q3 2026 was €1 565 with employees.
Turnover
1 565 €
↑ 8.4% vs Q2 2026
State taxes
—
Labour taxes
—
Employees
—
Q3 2026 · data from the Tax and Customs Board (EMTA)
Position in the industry
- Turnover · Q3 2026 1 565 €above 16% of companiesindustry median 14 442 € · companies in the industry: 318
- Revenue · 2025 39 533 €above 85% of companiesindustry median 0 € · companies in the industry: 1 073
- Net profit margin · 2025 1.5 %above 35% of companiesindustry median 13.5 % · companies in the industry: 597
Taxes and turnover
- Company
- Industry median
Industry: Scientific research and development (the EMTAK division of the main activity). Median: half of the industry is above, half below.
| Quarter | Turnover, € | State taxes, € | Labour taxes, € | Employees |
|---|---|---|---|---|
| Q3 2026 | 1 565 | — | — | — |
| Q2 2026 | 1 444 | — | — | — |
| Q1 2026 | 1 533 | — | — | — |
| Q4 2025 | 1 367 | — | — | — |
| Q3 2025 | 15 359 | — | — | — |
| Q2 2025 | 2 712 | — | — | — |
| Q1 2025 | 593 | — | — | — |
| Q4 2024 | 2 322 | — | — | — |
| Q3 2024 | 2 014 | — | — | — |
| Q2 2024 | 10 989 | — | — | — |
| Q1 2024 | 6 132 | — | — | — |
| Q4 2023 | 6 728 | — | — | — |
| Q3 2023 | — | 9 197 | 9 820 | — |
| Q2 2023 | 4 257 | 10 773 | 11 531 | 2 |
| Q1 2023 | 5 625 | 7 955 | 8 476 | 3 |
| Q4 2022 | 2 770 | 7 683 | 8 181 | 2 |
| Q3 2022 | 5 253 | 6 398 | 6 837 | 2 |
| Q2 2022 | 4 979 | 3 827 | 4 149 | 2 |
| Q1 2022 | 4 269 | 3 827 | 4 149 | 1 |
Financials by year
- Company
- Industry median
Industry: Scientific research and development (the EMTAK division of the main activity). Median: half of the industry is above, half below.
- Company
- Industry median
Industry: Scientific research and development (the EMTAK division of the main activity). Median: half of the industry is above, half below.
- Company
- Industry median
Industry: Scientific research and development (the EMTAK division of the main activity). Median: half of the industry is above, half below.
- Company
- Industry median
Industry: Scientific research and development (the EMTAK division of the main activity). Median: half of the industry is above, half below.
| Year | Revenue, € | Net profit, € | Labour costs, € | Assets, € | Equity, € | Employees |
|---|---|---|---|---|---|---|
| 2025 | 39 533 | 607 | 0 | 155 351 | 102 888 | 0 |
| 2024 | 17 088 | 3 661 | 0 | 133 498 | 102 281 | 0 |
| 2023 | 19 417 | 5 356 | 51 526 | 129 069 | 98 620 | 1 |
| 2022 | 15 533 | 775 | 68 688 | 111 842 | 95 736 | 2 |
| 2021 | 22 768 | 17 347 | 22 853 | 99 719 | 94 960 | 1 |
| 2020 | 19 639 | -7 216 | 0 | 77 857 | 77 613 | 0 |
| 2019 | 32 893 | -37 185 | 0 | 84 973 | 84 829 | 0 |
| 2018 | — | — | — | — | — | 0 |
| 2017 | — | — | — | — | — | 1 |
| 2016 | — | — | — | — | — | 1 |
| 2015 | — | — | — | — | — | 1 |
| 2014 | — | — | — | — | — | 0 |
| 2013 | — | — | — | — | — | 0 |
| 2012 | — | — | — | — | — | 0 |
| 2011 | — | — | — | — | — | 0 |
| 2010 | — | — | — | — | — | 0 |
| 2009 | — | — | — | — | — | 1 |
| 2008 | — | — | — | — | — | 0 |
Figures from the company’s own (non-consolidated) balance sheet and income statement. A loss is shown with a minus sign.
Financial ratios for 2025
Net profit margin
1.5 %
Net profit / revenue
Return on equity (ROE)
0.6 %
Net profit / equity
Return on assets (ROA)
0.4 %
Net profit / assets
Equity ratio
66.2 %
Equity / assets
Debt ratio
33.8 %
Liabilities / assets
Current ratio
2.37
Current assets / current liabilities
Annual reports
| Year | Period | Filed | Report | Documents |
|---|---|---|---|---|
| 2025 | 1 Jan 2025 – 31 Dec 2025 | 30 Jun 2026 | Company’s own | e-Äriregister |
| 2024 | 1 Jan 2024 – 31 Dec 2024 | 30 Jun 2025 | Company’s own | e-Äriregister |
| 2023 | 1 Jan 2023 – 31 Dec 2023 | 8 Aug 2024 | Company’s own | e-Äriregister |
| 2022 | 1 Jan 2022 – 31 Dec 2022 | 3 Jul 2023 | Company’s own | e-Äriregister |
| 2021 | 1 Jan 2021 – 31 Dec 2021 | 12 Jul 2022 | Company’s own | e-Äriregister |
| 2020 | 1 Jan 2020 – 31 Dec 2020 | 29 Jun 2021 | Company’s own | e-Äriregister |
| 2019 | 1 Jan 2019 – 31 Dec 2019 | 30 Oct 2020 | Company’s own | e-Äriregister |
Board
- Kaia PalmBoard member · since 5 May 2008
- Toomas NeumanBoard member · since 5 May 2008
- Madis PrinkBoard member · since 7 Jun 2012
- Nasdaq CSD SEKeeper of the share register · since 28 Sep 2017
Right of representation
Any member of the management board may represent the private limited company in all transactions.
Owners
- Omanikukonto: BIOINF OÜLegal person · 11359595 · 1 143 €
- Omanikukonto: OÜ INDIPROLegal person · 11371231 · 1 143 €
- Omanikukonto: JAMES RICHARD ROSANatural person · 254 €
Beneficial owners
- JAMES RICHARD ROSADirect ownership · USA · since 19 Oct 2018
- Kaia PalmDirect ownership · since 19 Oct 2018
- Toomas NeumanDirect ownership · since 19 Oct 2018
Founders and other persons
- BIOINF OÜFounder · 20 000 € · 2 May 2008
- OÜ IndiProFounder · 20 000 € · 2 May 2008
Related companies
Activities (EMTAK)
- 72101Research and experimental development on natural sciences and engineering Main
Rulings
All rulings (PDF)| Number, date | Title | Deadline | State | Document |
|---|---|---|---|---|
| Ä 10118155 / M3 8 Jul 2024 |
Warning of deletion from the register: annual report not filed | 11 Oct 2024 | Deficiencies eliminated 9 Aug 2024 |
|
| Ä 10118155 / 12 5 Apr 2019 |
Amendment entry | In force 5 Apr 2019 |
||
| Ä 10118155 / 11 17 Jan 2018 |
Amendment entry | In force 17 Jan 2018 |
||
| Ä 10118155 / 10 30 Nov 2017 |
Amendment entry | In force 30 Nov 2017 |
||
| Ä 10118155 / 9 28 Sep 2017 |
Amendment entry | In force 28 Sep 2017 |
||
| Ä 10118155 / 8 11 Jun 2015 |
Amendment entry | In force 11 Jun 2015 |
||
| Ä 10118155 / 7 20 Jan 2015 |
Entry refused: deficiencies not eliminated | In force 5 Feb 2015 |
||
| Ä 10118155 / M2 19 Dec 2014 |
Ruling to eliminate deficiencies | 18 Jan 2015 | In force 19 Dec 2014 |
|
| Ä 10118155 / 6 7 Jun 2012 |
Amendment entry | In force 7 Jun 2012 |
||
| Ä 10118155 / M1 31 May 2012 |
Ruling to eliminate deficiencies | 15 Jun 2012 | Deficiencies eliminated 4 Jun 2012 |
|
| Ä 10118155 / 5 28 Feb 2012 |
Entry refused: deficiencies not eliminated | In force 28 Feb 2012 |
||
| Ä 10118155 / 4 17 Nov 2011 |
Amendment entry | In force 17 Nov 2011 |
||
| Ä 118155 / 3 2 Jun 2009 |
Amendment entry | In force 2 Jun 2009 |
||
| Ä 118155 / 2 9 Feb 2009 |
Note on registration of shares in the Estonian central register of securities | In force 9 Feb 2009 |
||
| Ä 118155 2 May 2008 |
First entry | In force 5 May 2008 |
Sources: e-Äriregister and EMTA. Data updated 31 Oct 2026. Open at the source ↗ · Report an error in the data